Takeda Pharmaceutical Co., Ltd. (TAK)
16.41
+0.05
(+0.31%)
USD |
NYSE |
Apr 28, 16:00
16.60
+0.19
(+1.16%)
Pre-Market: 20:00
Takeda Pharmaceutical Total Liabilities (Quarterly) : 49.54B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sanofi | -- |
| Eli Lilly & Co. | 85.94B |
| Protagonist Therapeutics, Inc. | 55.19M |
| Denali Therapeutics, Inc. | 131.09M |
| Johnson & Johnson | 119.71B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.30B |
| Shareholders Equity (Quarterly) | 48.76B |
| Debt to Equity Ratio | 0.635 |
| Current Ratio | 1.194 |
| Net Debt Paydown Yield | 1.77% |